Cerus (CERS) Shares Outstanding (2010 - 2026)
Cerus' (CERS) quarterly Shares Outstanding (Entity) came in at $201.5 million in Q2 2026, up 5.13% year-over-year from $191.7 million in Q2 2025, and up 0.58% quarter-over-quarter from $200.4 million in Q1 2026.
Analysis
Cerus (CERS) Shares Outstanding (2010 - 2026) Analysis & Trends
Cerus has disclosed Shares Outstanding (Entity) across 17 years of filings, most recently posting $201.5 million for Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) rose 5.13% year-over-year to $201.5 million; the TTM figure through Jun 2026 stood at $201.5 million (up 5.13% YoY), while the FY2025 annual figure was $192.1 million, up 3.43% from the prior year.
- Shares Outstanding (Entity) came in at $201.5 million for Q2 2026 at Cerus, up from $200.4 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $201.5 million in Q2 2026 to a low of $176.9 million in Q1 2022.
- Average Shares Outstanding (Entity) over 5 years is $185.7 million, with a median of $185.1 million recorded in 2024.
- Year-over-year, Shares Outstanding (Entity) grew 2.06% in 2023 and increased 5.13% in 2026.
- Over 5 years, Shares Outstanding (Entity) stood at $177.6 million in 2022, then advanced by 2.06% to $181.2 million in 2023, then rose by 2.49% to $185.8 million in 2024, then rose by 3.43% to $192.1 million in 2025, then rose by 4.88% to $201.5 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $201.5 million in Q2 2026, $200.4 million in Q1 2026, and $192.1 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 383.50 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 576.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 493.20 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 382.20 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Cerus | 504.42 Mn | 448.16 Mn | 29.53 Mn | 200.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 200.57 Mn |
| Mar 31, 2026 | 194.14 Mn |
| Dec 31, 2025 | 190.59 Mn |
| Sep 30, 2025 | 191.83 Mn |
| Jun 30, 2025 | 191.30 Mn |
| Mar 31, 2025 | 187.07 Mn |
| Dec 31, 2024 | 184.56 Mn |
| Sep 30, 2024 | 185.42 Mn |
| Jun 30, 2024 | 184.98 Mn |
| Mar 31, 2024 | 182.09 Mn |
| Dec 31, 2023 | 180.27 Mn |
| Sep 30, 2023 | 180.94 Mn |
| Jun 30, 2023 | 180.61 Mn |
| Mar 31, 2023 | 178.27 Mn |
| Dec 31, 2022 | 176.55 Mn |
| Sep 30, 2022 | 177.24 Mn |
| Jun 30, 2022 | 176.94 Mn |
| Mar 31, 2022 | 174.48 Mn |
| Dec 31, 2021 | 171.28 Mn |
| Sep 30, 2021 | 171.90 Mn |